Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer
NCT00003097 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 175
Last updated 2009-02-09
Summary
RATIONALE: A low-fat, balanced diet may prevent disease progression in patients with nonmelanomatous skin cancer.
PURPOSE: Randomized phase II trial to study the effectiveness of a low-fat, balanced diet to prevent disease progression in patients with nonmelanomatous skin cancer.
Conditions
- Non-Melanomatous Skin Cancer
Interventions
- OTHER
-
preventative dietary intervention
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Baylor College of Medicine
lead OTHER
Principal Investigators
-
Homer Black, PhD · Baylor College of Medicine
Study Design
- Purpose
- PREVENTION
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1989-04-30
Countries
- United States
Study Locations
More Related Trials
-
Melanoma Risk Assessment & Tailored Intervention
NCT01356771 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
NCT06548789 ·Status: RECRUITING ·Phase: PHASE2
-
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT06400550 ·Status: RECRUITING
-
Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma
NCT00963664 ·Status: WITHDRAWN ·Phase: PHASE2
-
Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
NCT00004196 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Families With Melanoma
NCT00445783 ·Status: UNKNOWN
-
Targeted Intervention for Melanoma Prevention
NCT00394134 ·Status: COMPLETED ·Phase: NA
-
Symptom Burden in Patients With Cancer- and Treatment-Related Skin Problems
NCT01193036 ·Status: TERMINATED
-
Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
NCT00295906 ·Status: UNKNOWN ·Phase: NA
-
Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy
NCT02857374 ·Status: COMPLETED ·Phase: NA
-
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
NCT03028948 ·Status: COMPLETED ·Phase: NA
-
Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients
NCT01003626 ·Status: WITHDRAWN ·Phase: NA
-
3-month Aerobic and Resistance Exercise Intervention for Individuals Diagnosed With Melanoma
NCT03825913 ·Status: TERMINATED ·Phase: NA
-
Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg
NCT00003789 ·Status: COMPLETED ·Phase: PHASE3
-
Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
NCT00996827 ·Status: TERMINATED
-
Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma
NCT03913923 ·Status: UNKNOWN ·Phase: PHASE2
-
Boron Neutron Capture Therapy in Treating Patients With Melanoma
NCT00059800 ·Status: COMPLETED ·Phase: PHASE2
-
Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy
NCT05020912 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Investigate the Safety and Activity of Aldoxorubicin Plus Ifosfamide/Mesna in Subjects With Metastatic Soft Tissue Sarcoma
NCT02235701 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin Cancers
NCT00432471 ·Status: COMPLETED ·Phase: NA
-
Bone Loss in Melanoma Survivors Receiving Immunotherapy
NCT04516122 ·Status: TERMINATED
-
Study of PI-88 in Patients With Advanced Melanoma
NCT00068172 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
NCT00002669 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Study of TPI 287 for Patients With Metastatic Melanoma
NCT01340729 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors
NCT03946007 ·Status: COMPLETED